As of April 16, 2025, CalAmp (CAMP) has a market cap of $37.298 million USD. According to our data, CalAmp is ranked No.8248 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $37.30 M |
-64.56%
|
Dec 31, 2024 | $0.11 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() BioNTech
BNTX
|
$23.80 B |
0.001 M
|
![]() Germany
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
Market Cap | = | CAMP Stock Price | * | CAMP Shares Outstanding |
= | $1.85 | * | 20.16 M | |
= | $37.30 M |